• Your Selections:

Refine Results

date

Topics

Content Type

Tags

Round 3: Legal Challenges to Contraceptive Coverage at SCOTUS

This brief explains how the new regulations issued by the Trump Administration would change the contraceptive coverage requirement for employers and affect women’s coverage, the legal positions for challenging and defending these regulations, the potential rulings, and the broader ramifications.

A Look at Online Platforms for Contraceptive and STI Services during the COVID-19 Pandemic

There has been a proliferation of online services in recent years that seek to offer individuals that cannot make it to a clinic or do not have an established source of care access to some contraceptive methods and STI testing through a telemedicine platform, usually a website or a smartphone application. This data note provides an overview of options available for the online management of sexual and reproductive health services during the coronavirus pandemic and discusses the opportunities and limitations of these platforms in terms of availability and cost.

Online Contraceptive and STI Services During COVID-19: What are the options?

A new KFF issue brief provides an overview of online options for contraceptive and STI services during the COVID-19 pandemic. This resource also includes an interactive table that shows which platforms are available in each state and which accept private insurance or Medicaid.

Telemedicine and Pregnancy Care

This brief outlines how telemedicine is currently used in obstetrical care, how these services are financed and regulated, and reviews federal efforts to expand the use of telemedicine, particularly to address maternal health disparities.

Sexually Transmitted Infections (STIs): An Overview, Payment, and Coverage

More people have health insurance than ever before under the Affordable Care Act (ACA), which emphasizes preventive care, including no-cost HIV and STI counseling and screening for recommended populations. This fact sheet examines trends and disparities in STI prevalence, reviews the STI screening and preventive care coverage policies for private insurance and public programs, and discusses coverage gaps and confidentiality concerns in the provision of these services.